Comparison · NSE · data 2026-11-02
Molbio Diagnostics Limited vs Sahajanand Medical Technologies Limited
In plain words
Size: Molbio Diagnostics Limited is about 3.1 times the market value of Sahajanand Medical Technologies Limited.
Differences in the numbers, not a recommendation of either stock.
Side by side
| MOLBIO | SMT | |
|---|---|---|
| Price | ₹1,273.1 | ₹456.5 |
| Market cap | ₹14,689 cr | ₹4,675 cr |
| P/E | — | — |
| P/B | — | — |
| ROE | 13.8% | — |
| ROCE | 19.2% | — |
| Debt / equity | 0.3 | — |
| Operating margin | — | — |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 58.1% | — |
| Profit growth, 3 years (yearly) | — | — |
| 1-year return | 57.8% | 23.0% |
| Revenue, last 12 months | — | — |
| Net profit, last 12 months | — | — |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹59 cr | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 41.29% | — |
| Health check | Strong (8.3/10) | Strong (6.9/10) |